Publicaciones en colaboración con investigadores/as de University of California, San Francisco (13)

2023

  1. Enhanced recovery for liver transplantation: recommendations from the 2022 International Liver Transplantation Society consensus conference

    The Lancet Gastroenterology and Hepatology, Vol. 8, Núm. 1, pp. 81-94

2022

  1. Transplantation, HIV Serostatus, and Registry Data: Room for Improvement

    American Journal of Transplantation

2021

  1. Nonviral liver disease is the leading indication for liver transplant in the United States in persons living with human immunodeficiency virus

    American Journal of Transplantation, Vol. 21, Núm. 9, pp. 3148-3156

2020

  1. Temporal Trends and Outcomes in Liver Transplantation for Recipients With HIV Infection in Europe and United States

    Transplantation, Vol. 104, Núm. 10, pp. 2078-2086

2018

  1. Outcomes of antiviral treatment in hepatitis C virus liver transplant patients off immunosuppression in the direct acting antivirals era: A case series

    Clinical Transplantation, Vol. 32, Núm. 7

  2. Use of a hepatitis C virus (HCV) RNA-positive donor in a treated HCV RNA-negative liver transplant recipient

    Transplant Infectious Disease, Vol. 20, Núm. 1

2016

  1. Key donor factors associated with graft loss among liver transplant recipients with human immunodeficiency virus

    Clinical Transplantation, Vol. 30, Núm. 9, pp. 1140-1145

  2. Liver Retransplantation in Patients with HIV-1 Infection: An International Multicenter Cohort Study

    American Journal of Transplantation, Vol. 16, Núm. 2, pp. 679-687

  3. Treatment of severe recurrent hepatitis C after liver transplantation in HIV infected patients using sofosbuvir-based therapy

    Alimentary Pharmacology and Therapeutics, Vol. 43, Núm. 12, pp. 1319-1329

2015

  1. Advances in therapy for HIV/Hepatitis C virus-coinfected patients in the liver transplant setting

    Clinical Infectious Diseases, Vol. 60, Núm. 1, pp. 108-116

  2. Hepatitis C genotype influences post-liver transplant outcomes

    Transplantation, Vol. 99, Núm. 4, pp. 835-840

  3. Sofosbuvir, simeprevir, and ribavirin for the treatment of hepatitis C virus recurrence in human immunodeficiency virus/hepatitis C virus-coinfected liver transplant recipients

    Liver Transplantation

2007

  1. AIDS by mother-to-child transmission: Survival analysis of cases followed from 1983 to 2002 in different regions of Brazil

    Cadernos de Saude Publica, Vol. 23, Núm. SUPPL. 3